The frequency of cardiovascular death , myocardial infarction , or stroke in current smokers was significantly lower with prasugrel ( @ % ) vs. clopidogrel ( @ % ) , but there was no difference in non-smokers ( @ % vs. @ % ) , with significant interaction between treatment and baseline smoking status ( P = @ ) .